Abe M, Nakamura F, Tan F, Deddish P A, Colley K J, Becker R P, Skidgel R A, Erdös E G
Department of Pharmacology, University of Illinois College of Medicine at Chicago 60612, USA.
Hypertension. 1995 Dec;26(6 Pt 1):891-8. doi: 10.1161/01.hyp.26.6.891.
Many properties of urinary kallikrein are well characterized, but the intracellular processing of prokallikrein and release by kidney cells have yet to be clarified. We report here on the synthesis of prokallikrein in Madin-Darby canine kidney (MDCK) cells transfected with rat submaxillary gland kallikrein cDNA and on its activation by MDCK cells and by an enriched liver Golgi membrane preparation. Transfected MDCK cells secreted only prokallikrein at both the apical and basolateral sides in about a 4:1 ratio, but cells transfected with kallikrein cDNA in reverse orientation or untreated cells released only traces of the enzyme. Prokallikrein, in culture medium or in homogenized MDCK cells, was fully activated by trypsin but activated only to 44% by thermolysin. Prokallikrein was synthesized and released into the medium at a high rate: the enzyme secreted by 5 x 10(6) cells in 24 hours cleaved 46 nmol/min D-Val-Leu-Arg-7-amino-4-methylcoumarin and liberated 63 ng/min bradykinin after activation. Immunocytology indicated the association of prokallikrein with the Golgi apparatus in the transfected cells. Antiserum to rat urinary kallikrein detected a single band in a Western blot of conditioned medium and also immunoprecipitated the enzyme. Aprotinin inhibited activated prokallikrein. Although MDCK cells released prokallikrein, their homogenates activated prokallikrein at both pH 5.5 and 7.5. Prokallikrein was also activated by a highly enriched liver Golgi membrane fraction and by an endoplasmic reticulum preparation, but the Golgi preparation was 38-fold more active. The activation was blocked significantly by inhibitors of serine proteases and less by cysteine protease inhibitors.(ABSTRACT TRUNCATED AT 250 WORDS)
尿激肽释放酶的许多特性已得到充分表征,但前激肽释放酶的细胞内加工过程以及肾细胞的释放情况仍有待阐明。我们在此报告,用大鼠颌下腺激肽释放酶cDNA转染的Madin-Darby犬肾(MDCK)细胞中前激肽释放酶的合成,以及MDCK细胞和富集的肝高尔基体膜制剂对其的激活作用。转染的MDCK细胞在顶端和基底外侧均仅以约4:1的比例分泌前激肽释放酶,但反向转染激肽释放酶cDNA的细胞或未处理的细胞仅释放痕量的该酶。培养基或匀浆的MDCK细胞中的前激肽释放酶可被胰蛋白酶完全激活,但被嗜热菌蛋白酶仅激活至44%。前激肽释放酶以高速率合成并释放到培养基中:5×10⁶个细胞在24小时内分泌的酶在激活后每分钟可裂解46 nmol的D-缬氨酸-亮氨酸-精氨酸-7-氨基-4-甲基香豆素,并每分钟释放63 ng缓激肽。免疫细胞化学表明转染细胞中前激肽释放酶与高尔基体相关。抗大鼠尿激肽释放酶抗血清在条件培养基的蛋白质印迹中检测到一条带,并且也免疫沉淀了该酶。抑肽酶抑制活化的前激肽释放酶。尽管MDCK细胞释放前激肽释放酶,但其匀浆在pH 5.5和7.5时均可激活前激肽释放酶。前激肽释放酶也可被高度富集的肝高尔基体膜组分和内质网制剂激活,但高尔基体制剂的活性高38倍。丝氨酸蛋白酶抑制剂可显著阻断该激活作用,而半胱氨酸蛋白酶抑制剂的阻断作用较小。(摘要截短于250字)